Yew Bio-Pharm Group, Inc. Operating Lease, Payments
Yew Bio-Pharm Group, Inc. reported Operating Lease, Payments of $67.39 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2021-11-15
- Yew Bio-Pharm Group, Inc. operating lease, payments for the quarter ending 2021-09-30 was $16.20K.
- Yew Bio-Pharm Group, Inc. operating lease, payments for the quarter ending 2021-06-30 was $12.38K, a 31.01% decline year-over-year.
- Yew Bio-Pharm Group, Inc. operating lease, payments for the quarter ending 2021-03-31 was $38.81K, a 11.77% increase year-over-year.
- Yew Bio-Pharm Group, Inc. operating lease, payments for the quarter ending 2020-12-31 was $39.68K, a 42.60% decline year-over-year.
- Yew Bio-Pharm Group, Inc. operating lease, payments for fiscal 2020 was $74.40K, a 41.48% decline from fiscal 2019.
- Yew Bio-Pharm Group, Inc. operating lease, payments for fiscal 2019 was $127.13K.
- Yew Bio-Pharm Group, Inc. operating lease, payments for fiscal 2019 was $127.13K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | $16.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $28.58K derived: sum of 2 quarters · filed 2021-11-15 | $67.39K 10-Q · filed 2021-11-15 | $107.07K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | $12.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $51.20K 10-Q · filed 2021-08-16 | $90.87K derived: sum of 3 quarters · filed 2021-08-16 | $72.92K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-03-31 | $38.81K 10-Q · filed 2021-05-17 | $78.49K derived: sum of 2 quarters · filed 2021-05-17 | $60.54K derived: sum of 3 quarters · filed 2021-11-15 | $78.49K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-12-31 | $39.68K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $21.73K derived: sum of 2 quarters · filed 2021-11-15 | $39.68K derived: sum of 3 quarters · filed 2021-11-15 | $74.40K 10-K · filed 2021-03-30 | |
| 2020-09-30 | -$17.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $34.73K 10-Q · filed 2021-11-15 | $60.26K 10-Q · filed 2020-11-13 | $103.85K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $17.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $52.67K 10-Q · filed 2021-08-16 | $121.80K derived: sum of 3 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $34.73K 10-Q · filed 2021-05-17 | $103.85K derived: sum of 2 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $69.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $127.13K 10-K · filed 2021-03-30 | |||
| 2019-12-30 | $69.12K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $78.81K derived: sum of 2 quarters · filed 2020-11-13 | $91.60K derived: sum of 3 quarters · filed 2020-11-13 | $127.13K 10-K · filed 2020-05-14 | |
| 2019-09-30 | $9.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $22.47K derived: sum of 2 quarters · filed 2020-11-13 | $58.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $12.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $48.32K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $35.53K 10-Q · filed 2020-06-29 |